Tax Group Of The Year: Mayer Brown

News

• May 30

  2023

  Mayer Brown advised SERB Pharmaceuticals on the structuring of the acquisition of the US rights to bentracimab, a ticagrelor reversal agent, from SFJ Pharmaceuticals

• May 08

  2023

  Mayer Brown adds former IRS international tax lawyer Sonal Majmudar

• May 05

  2023

  Mayer Brown advises new client Sullivan Street Partners alongside Souter Investments on their acquisition of the diagnostic services business of Johnson Matthey, Tracerco

• April 24

  2023

  Mayer Brown advises TUI on the sale of its stake in Peakwork AG

• March 30

  2023

  Mayer Brown advises AIF Capital Group on the acquisition of three care facilities in Lübeck, Sulzbach and Wetzlar